Big data analysis of outcomes in non-small cell lung cancer at a regional cancer institute with a coordinated precision medicine program. Interplatform and cross-cohort meta-analysis of tumor ...

Based on WHO classification, Breast carcinomas have varying histomorphologies and each subtype has its own translational importance. Invasive lobular ...

NCCN Guidelines® recommend FES PET for systemic staging in certain patients with invasive lobular cancer (ILC), which could facilitate greater diagnostic accuracy, earlier interventions, better ...

Sichun Yang, PhD, a member of Case CCC's Molecular Oncology Program, and Alberto Montero, MD, a Developmental Therapeutics Program member, are looking for patient advocates for a follow-up study to ...

Rates of one type of breast cancer — invasive lobular carcinoma — have been rising in the United States more than three times faster than those of all other breast cancers combined over the past ...

While researchers work to improve lobular breast cancer screening, innovative treatments are improving outcomes for patients with the condition, which is diagnosed in more than 40,000 Americans each ...

Lobular breast cancer patients gathered at Fred Hutch Cancer Center last week for a two-hour program featuring patient stories, epidemiological findings and new developments in screening and clinical ...

Invasive lobular carcinoma accounts for about 10% of breast cancer diagnoses. Its incidence is increasing at the rate of 2.8% annually -- more than triple that of other breast cancers combined. This ...

TUESDAY, Oct. 14, 2025 (HealthDay News) -- The incidence rates for invasive lobular carcinoma (ILC) increased from 2012 to 2021 for all racial and ethnic groups, according to a study published online ...

Researchers in Rome set out to examine the predictors and prevalence of nodal metastases in 491 women with early-stage, clinically node-negative ILC. Roughly 1 in 5 participants had nodal metastases, ...